Abiopharma

Grayscale Investments Launches the Lowest Gross Fee Hyperliquid ETP in the U.S. with Grayscale® Hyperliquid Staking ETF (Ticker: HYPG)

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Oshkosh Defense Secures $142 Million Orders for FMTV A2, Reflecting Continued Global Demand

Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors

Intercontinental Exchange Joins Anthropic’s Project Glasswing

Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity

Teledyne HiRel Semiconductors Unveils Space-Screened, Ultra-Low Power 4 GHz Wideband Low Noise Amplifier

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics USA - English USA - English

General Mills to Webcast Fiscal 2026 Fourth Quarter and Full Year Earnings Results on July 1, 2026

Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA